Manipal Health IPO: Surge in Pan-India Footprint Drives "Subscribe Long Term" Rating Amid Strong Operational Scale
Operating at Scale: Manipal's Massive Healthcare Network
Manipal Health Enterprises Ltd is poised as a key player in India's rapidly expanding healthcare sector. The company operates an extensive pan-India network of multispecialty hospitals, offering services that span from basic outpatient care to complex tertiary and quaternary interventions. As of March 31, 2026, the company managed 49 hospitals across 14 states and union territories. This operational scale highlights its dominant presence among private hospital chains in India.The network boasts a significant capacity, holding 13,037 licensed beds across various regions. By leveraging this vast infrastructure, Manipal has established itself as the largest pan-India multispecialty hospital chain by bed capacity. Furthermore, it holds the position of the second-largest hospital chain by the sheer number of facilities in the country.
Regional Dominance and Footprint
Manipal Health exhibits strong regional concentration, effectively dominating key markets across India. The company's operational strength is particularly evident in three core regions: Karnataka, Maharashtra and Goa, and a cluster of states in Eastern India. In Karnataka, Manipal stands as the largest private hospital chain, operating 6,404 licensed beds. Similarly, it leads the market in both Maharashtra and Goa with 2,188 licensed beds.The commitment to regional expansion is also visible in Eastern India. The company operates 2,887 licensed beds across West Bengal, Odisha, Jharkhand, and Sikkim. These numbers solidify Manipal's wide geographical footprint among private hospital operators in the country. Licensed beds represent the total number of hospital beds approved by regulatory authorities at each facility.
Financial Performance and IPO Valuation
The company reported a strong financial performance for Fiscal 2026. Manipal achieved the second-highest revenue from operations among all private hospital chains in India, reporting ₹103,357.51 million, or ₹109,356.18 million on a pro forma basis. This robust operational scale is underpinned by strong financial performance across its diverse regional portfolio.Anand Rathi has assessed the IPO's valuation and outlook for Manipal Health Enterprises. The company is valued at a Price-to-Earnings (PE) ratio of 85.4x based on its FY26 earnings. Post the equity issuance, the market capitalization is projected to be Rs 7,76,056 million.
Analyst View: A "Subscribe Long Term" Recommendation
Despite the high valuation metrics, Anand Rathi has offered a "Subscribe Long Term" rating for the IPO. The firm believes that while the stock may appear fully priced in some aspects of its current valuation, the fundamentals and market positioning warrant investor confidence. This assessment suggests enduring value potential backing Manipal's immense operational capacity in the burgeoning healthcare sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.